FWD Group Holdings Limited (“FWD Group” or “FWD”) announced it has signed a cooperation agreement with Roche Diagnostics Asia Pacific Pte Ltd (“Roche”) to leverage Roche’s navify® digital healthcare solutions and advanced diagnostic methodologies for innovation in FWD’s health insurance services in Asia.

The collaboration will span an initial period of three years. It aims to bring to market health solutions at the forefront of modern medicine and healthcare to improve health outcomes for FWD’s customers in a cost-effective way.

Binayak Dutta, Managing Director, FWD Group, said “At FWD, we believe that shifting the emphasis from a reactive to a proactive healthcare model is critical to giving our customers the best opportunity to celebrate living. The integration of advanced diagnostics technology into the healthcare ecosystem can improve patient outcomes in ways that we’ve never seen before.”

In May, FWD Group announced the introduction of FWD HealthyMe, a new health business unit. FWD HealthyMe aims to develop innovative partnerships with healthcare providers and industry leaders and be a trusted proactive health partner to customers in Asia. It builds on the strong foundations provided by FWD’s suite of life insurance, critical illness and medical offerings.

Dr. Sarah Salvilla, Group Chief Health Officer, FWD Group, said “By working with Roche, we aim to accelerate health insurance innovation in Asia as part of our vision of changing the way people feel about insurance. Roche is a recognised leader in diagnostics, having delivered 29 billion tests last year alone globally, and we’re delighted to partner with them.”

navify® digital solutions from Roche Diagnostics are designed to transform laboratory and clinical data into actionable insights, delivering operational and financial value, and helping to personalise care along each individual healthcare journey.

Lance Little, Managing Director, Roche Diagnostics Asia Pacific, said, “We are delighted to collaborate with FWD Group to develop opportunities for early diagnosis to their customers, leveraging the latest research and technology. Earlier diagnoses lead to better health outcomes and insights that can lead to behaviour and lifestyle changes, which can keep a person healthy and out of hospital. Others might reveal an imminent threat and lead to a life-saving decision.”

The agreement between FWD Group and Roche is expected to be activated progressively in selected FWD markets in the coming months.

About FWD Group

FWD Group is a pan-Asian life and health insurance business with more than 12 million customers across 10 markets, including some of the fastest-growing insurance markets in the world. The company was established in 2013 and is focused on changing the way people feel about insurance. FWD’s customer-led and digitally enabled approach aims to deliver innovative propositions, easy-to-understand products and a simpler insurance experience.

For more information, please visit www.fwd.com